BL
IRD

Bleichroeder LP’s Opus Genetics IRD Stock Holding History

Bleichroeder LP’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.03M Hold
736,842
– – 0.54% 27
2026
Q1 		$3.35M Hold
736,842
– – 0.58% 23
2025
Q4 		$1.48M Hold
736,842
– – 0.26% 31
2025
Q3 		$1.22M Hold
736,842
– – 0.24% 33
2025
Q2 		$694K Hold
736,842
– – 0.17% 37
2025
Q1 		$723K Buy
+736,842
New +$823K 0.19% 33

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bleichroeder LP's IRD Position: Q2 2026 in Review

Bleichroeder LP held its Opus Genetics (IRD) position steady in Q2 2026 at 736,842 shares worth $3.03M. The position accounts for 0.54% of the portfolio, ranked #27.

Bleichroeder LP first reported a position in IRD in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.35M in Q1 2026. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Bleichroeder LP held 736,842 shares of Opus Genetics worth $3.03M as of Q2 2026.
  • Bleichroeder LP left its Opus Genetics share count unchanged in Q2 2026.
  • Opus Genetics made up 0.54% of Bleichroeder LP's portfolio in Q2 2026, its #27 holding.
  • Bleichroeder LP first reported a position in Opus Genetics in Q1 2025 and has held it in 6 quarters since.
  • Bleichroeder LP's Opus Genetics position peaked at $3.35M in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.